Advances in Melanoma Care: A Multidisciplinary Symposium

Host: The Angeles Clinic and Research Institute (A Cedars-Sinai Affiliate) Date: Thursday, May 21, 2026 Time: 4:00 PM PT / 5:00 PM MT / 6:00 PM CT / 7:00 PM ET This 16th annual symposium brings together leading melanoma specialists from The Angeles Clinic, Hadassah Cancer Research Institute., and Massachusetts Brigham General Cancer Institute for a comprehensive afternoon program covering the full spectrum of melanoma care — from surgical and adjuvant approaches through cutting-edge cellular and targeted therapies, with dedicated patient resources and a Q&A session to close. The program features a strong multidisciplinary lineup — combining medical oncology, surgical oncology, and cellular therapy expertise — anchored by The Angeles Clinic team (Drs. Hamid, Mehmi, and Fischer) with national experts from Memorial Sloan Kettering Cancer Center (Dr. Smithy) Hadassah Cancer Research Institute (Dr. Cohen) and Massachusetts Brigham General Cancer Institute (Dr. Sullivan), plus patient-advocacy representation from AIM at Melanoma. Key Themes Covered Treatment sequencing: Adjuvant and neoadjuvant strategies, both medical and surgical Immunotherapy frontier: T-cell therapies and first-line systemic options Precision medicine: Targeted therapies for actionable mutations Special populations: Uveal melanoma and other rare subtypes What’s next: Novel and emerging therapeutics Patient support: Community resources via AIM at Melanoma The symposium runs approximately 2 hours 40 minutes, concluding with an open Q&A for attendees. Presenters & Topics 4:00 PM PT Welcome and Introductions Omid Hamid, MD Co-Director of Cutaneous Oncology The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate 4:10 PM PT Adjuvant/Neo Adjuvant Therapeutic Considerations Inderjit Mehmi, MD Medical Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate 4:30 PM PT (Neo) Adjuvant and Metastatic Surgical Considerations Trevan Fischer, MD Surgical Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate 4:50 PM PT T cell Therapies James W. Smithy, MD, MHS Melanoma Medical Oncologist & Cellular Therapist Memorial Sloan Kettering Cancer Center 5:10 PM PT First Line Therapies for Advanced Melanoma Jonathan Cohen, MD, PhD Senior Medical Oncologist and the Director of Clinical Research Hadassah Cancer Research Institute 5:30 PM PT Targeted Therapies Ryan Sullivan, MD Director Center for Melanoma Massachusetts Brigham General Cancer Institute 5:50 PM PT Uveal Melanoma & Rare Melanomas Inderjit Mehmi, MD Medical Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate 6:10 PM PT Novel Therapies in Melanoma Omid Hamid, MD Co-Director of Cutaneous Oncology The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate 6:30 PM PT AIM at Melanoma Patient Resources Ann Garst Taylor, CVA Director Community Engagement AIM at Melanoma 6:40 PM PT Q&A & Closing Remarks